This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa
The drug PRADAXA contains one active pharmaceutical ingredient (API):
1
Dabigatran
UNII SC7NUW5IIT - DABIGATRAN ETEXILATE MESYLATE
|
Dabigatran etexilate is a small molecule prodrug which does not exhibit any pharmacological activity. After oral administration, dabigatran etexilate is rapidly absorbed and converted to dabigatran by esterase-catalysed hydrolysis in plasma and in the liver. Dabigatran is a potent, competitive, reversible direct thrombin inhibitor and is the main active principle in plasma. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
PRADAXA 75mg Hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC | |
PRADAXA Coated granules | European Medicines Agency (EU) | MPI, EU: SmPC | |
PRADAXA 110mg Hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC | |
PRADAXA 150mg Hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
B01AE07 | Dabigatran etexilate | B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AE Direct thrombin inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 2753X, 2769R, 9318K, 9319L, 9320M, 9321N, 9322P, 9323Q |
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 504505101119316, 504505102115314, 504505103111312, 504505104118310, 504505105114319, 504505106110317, 504505107117315, 504505108113313 |
Country: CA | Health Products and Food Branch | Identifier(s): 02312433, 02312441, 02358808 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 28863-05-09, 28864-05-09, 30190-05-12 |
Country: EE | Ravimiamet | Identifier(s): 1343359, 1343360, 1343371, 1343382, 1343393, 1343405, 1538726, 1538737, 1538748, 1538759, 1538760, 1587258, 1587269 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 08442002, 08442003, 08442005, 08442006, 08442007, 08442011 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 115330, 115341, 115364, 442705 |
Country: FR | Base de données publique des médicaments | Identifier(s): 63484283, 65570603, 65693901 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 135048, 135051, 135055, 135056, 194659, 368206, 368212, 375293, 375296 |
Country: HK | Department of Health Drug Office | Identifier(s): 57315, 57316, 60516 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 36882, 36883, 60602, 60603, 60612, 60615, 60616, 60617, 60628, 60633, 60634, 60659, 60681, 60684, 60685 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 6317, 6318, 6319, 6320, 6321, 6685 |
Country: IT | Agenzia del Farmaco | Identifier(s): 038451011, 038451023, 038451035, 038451047, 038451062, 038451074, 038451086, 038451098, 038451100, 038451112, 038451124, 038451136, 038451148, 038451201, 038451213, 038451225, 038451237, 038451249, 038451252, 038451264 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1031768, 1031769, 1031770, 1031771, 1031772, 1031773, 1031774, 1031775, 1061808, 1061809, 1061810, 1061811, 1061812, 1061815, 1067398, 1067399, 1067400, 1067401, 1067402, 1091757, 1091758, 1091759, 1091760, 1091761, 1091762, 1091763 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 86983, 86991, 98361 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 13118, 13119, 14318 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100191706, 100191712, 100250679, 100455414, 100455421, 100455446, 100455453, 100455460, 100455478, 100455485 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W52942001, W52942002, W52942003, W52942004, W52943001, W52943002, W52943003, W52943004, W52943005, W57151001, W57151002, W57151003, W57151004, W57151005, W69037001, W69038001, W69039001, W69040001, W69041001, W69042001, W69043001 |
Country: SG | Health Sciences Authority | Identifier(s): 13697P, 13698P, 13941P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 11533041, 11533042, 11533043 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699693150042, 8699693150059, 8699693150097, 8699693150103, 8699693150127 |
Country: US | FDA, National Drug Code | Identifier(s): 0597-0108, 0597-0355, 0597-0360, 50090-3617, 50090-4480, 63629-8242 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 42/8.2/0130, 42/8.2/0131, 45/8.2/0162 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.